Advertisement

Ads Placeholder
Loading...

EuroEyes International Eye Clinic Limited

1846.HKHKSE
Healthcare
Medical - Care Facilities
HK$2.70
HK$0.01(0.37%)
Hong Kong Market opens in 46h 44m

EuroEyes International Eye Clinic Limited Fundamental Analysis

EuroEyes International Eye Clinic Limited (1846.HK) shows moderate financial fundamentals with a PE ratio of 11.29, profit margin of 10.56%, and ROE of 6.49%. The company generates $0.7B in annual revenue with weak year-over-year growth of 0.20%.

Key Strengths

Cash Position89.03%
PEG Ratio-2.82
Current Ratio3.81

Areas of Concern

ROE6.49%
We analyze 1846.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 42.5/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
42.5/100

We analyze 1846.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

1846.HK struggles to generate sufficient returns from assets.

ROA > 10%
4.22%

Valuation Score

Excellent

1846.HK trades at attractive valuation levels.

PE < 25
11.29
PEG Ratio < 2
-2.82

Growth Score

Weak

1846.HK faces weak or negative growth trends.

Revenue Growth > 5%
0.20%
EPS Growth > 10%
-37.50%

Financial Health Score

Excellent

1846.HK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.27
Current Ratio > 1
3.81

Profitability Score

Weak

1846.HK struggles to sustain strong margins.

ROE > 15%
6.49%
Net Margin ≥ 15%
10.56%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 1846.HK Expensive or Cheap?

P/E Ratio

1846.HK trades at 11.29 times earnings. This suggests potential undervaluation.

11.29

PEG Ratio

When adjusting for growth, 1846.HK's PEG of -2.82 indicates potential undervaluation.

-2.82

Price to Book

The market values EuroEyes International Eye Clinic Limited at 0.68 times its book value. This may indicate undervaluation.

0.68

EV/EBITDA

Enterprise value stands at 8.46 times EBITDA. This is generally considered low.

8.46

How Well Does 1846.HK Make Money?

Net Profit Margin

For every $100 in sales, EuroEyes International Eye Clinic Limited keeps $10.56 as profit after all expenses.

10.56%

Operating Margin

Core operations generate 16.92 in profit for every $100 in revenue, before interest and taxes.

16.92%

ROE

Management delivers $6.49 in profit for every $100 of shareholder equity.

6.49%

ROA

EuroEyes International Eye Clinic Limited generates $4.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

4.22%

Following the Money - Real Cash Generation

Operating Cash Flow

EuroEyes International Eye Clinic Limited generates strong operating cash flow of $196.72M, reflecting robust business health.

$196.72M

Free Cash Flow

EuroEyes International Eye Clinic Limited generates strong free cash flow of $131.69M, providing ample flexibility for dividends, buybacks, or growth.

$131.69M

FCF Per Share

Each share generates $0.41 in free cash annually.

$0.41

FCF Yield

1846.HK converts 15.18% of its market value into free cash.

15.18%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

11.29

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.82

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.68

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.20

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.27

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.06

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.08

vs 25 benchmark

How 1846.HK Stacks Against Its Sector Peers

Metric1846.HK ValueSector AveragePerformance
P/E Ratio11.2928.45 Better (Cheaper)
ROE6.49%763.00% Weak
Net Margin10.56%-45265.00% (disorted) Strong
Debt/Equity0.270.34 Neutral
Current Ratio3.812795.60 Strong Liquidity
ROA4.22%-16588.00% (disorted) Weak

1846.HK outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews EuroEyes International Eye Clinic Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

30.12%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

1844.15%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

146.70%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ